PTAB To Review Allergen Juvederm Patent At Heart Of IP Suit
The Patent Trial and Appeal Board said Thursday it will review an Allergan patent covering its injectable skin filler Juvederm, giving a boost to Prollenium US Inc.'s effort to fend off...To view the full article, register now.
Already a subscriber? Click here to view full article